The prevalence of and factors associated with chronic atrial fibrillation in Medicare/Medicaid-eligible dialysis patients.

[1]  W. Winkelmayer,et al.  The increasing prevalence of atrial fibrillation among hemodialysis patients. , 2011, Journal of the American Society of Nephrology : JASN.

[2]  Lorien S Dalrymple,et al.  Infection-related hospitalizations in older patients with ESRD. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  P. Kerr,et al.  Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. , 2010, Kidney international.

[4]  R. Foley,et al.  Mortality from Cancer among US Hemodialysis Patients, 1995–2005 , 2010, American Journal of Nephrology.

[5]  S. Seliger Comorbidity and confounding in end-stage renal disease. , 2010, Kidney international.

[6]  Zhi Huang,et al.  An improved comorbidity index for outcome analyses among dialysis patients. , 2010, Kidney international.

[7]  J. Wheeler,et al.  Provider monitoring and pay-for-performance when multiple providers affect outcomes: An application to renal dialysis. , 2009, Health services research.

[8]  R. Thadhani,et al.  Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. , 2009, Journal of the American Society of Nephrology : JASN.

[9]  R. Foley,et al.  Hemodialysis access at initiation in the United States, 2005 to 2007: Still “Catheter First” , 2009, Hemodialysis international. International Symposium on Home Hemodialysis.

[10]  P. Castellano,et al.  Atrial fibrillation in incident dialysis patients. , 2009, Kidney international.

[11]  D. Levy,et al.  Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study , 2009, The Lancet.

[12]  J. Klein,et al.  Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  Tong Liu,et al.  Atrial Fibrillation in End‐Stage Renal Disease , 2007, Pacing and clinical electrophysiology : PACE.

[14]  K. Kalantar-Zadeh,et al.  CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: Introduction: The Reverse Epidemiology Controversy , 2007, Seminars in dialysis.

[15]  K. Kalantar-Zadeh CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: What Is So Bad about Reverse Epidemiology Anyway? , 2007, Seminars in dialysis.

[16]  A. Schoolwerth,et al.  Racial disparities in the prevalence of cardiovascular disease among incident end-stage renal disease patients. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  J. Menzin,et al.  Warfarin Exposure and the Risk of Thromboembolic and Major Bleeding Events Among Medicaid Patients with Atrial Fibrillation , 2006, The Annals of pharmacotherapy.

[18]  A. Luke,et al.  Increasing body mass index and obesity in the incident ESRD population. , 2006, Journal of the American Society of Nephrology : JASN.

[19]  A. Yıldırır,et al.  Frequency of atrial fibrillation and factors related to its development in dialysis patients. , 2006, International journal of cardiology.

[20]  M. Valsecchi,et al.  Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  Yuchiao Chang,et al.  Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? , 2003, JAMA.

[22]  J. Pankow,et al.  Prediction of coronary heart disease in middle-aged adults with diabetes. , 2003, Diabetes care.

[23]  Yuchiao Chang,et al.  Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. , 2003, The New England journal of medicine.

[24]  A. Folsom,et al.  Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. , 2003, Journal of clinical epidemiology.

[25]  B. Kestenbaum,et al.  Elevated risk of stroke among patients with end-stage renal disease. , 2003, Kidney international.

[26]  S. Suissa Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies. , 2003, American journal of respiratory and critical care medicine.

[27]  Allen J. Taylor,et al.  Atrial fibrillation in chronic dialysis patients in the United states: risk factors for hospitalization and mortality , 2003, BMC Nephrology.

[28]  Martha J. Radford,et al.  Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation , 2001 .

[29]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[30]  M. Borrego,et al.  Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. , 2000, American heart journal.

[31]  D. Di Landro,et al.  Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients. , 2000, Clinical nephrology.

[32]  D. Singer,et al.  Warfarin Use among Ambulatory Patients with Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study , 1999, Annals of Internal Medicine.

[33]  D. Levy,et al.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.

[34]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[35]  N. Nakanishi,et al.  Electrocardiographic abnormalities in patients receiving hemodialysis. , 1996, American heart journal.

[36]  Elsayed Z Soliman,et al.  A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study). , 2011, The American journal of cardiology.

[37]  Ross Ward,et al.  United States Renal Data System , 2011 .

[38]  J. Mahnken,et al.  Considering health insurance: how do dialysis initiates with Medicaid coverage differ from persons without Medicaid coverage? , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[39]  David C. Murray,et al.  Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. , 1995, Kidney international.